General Information of the Cell Line
Cell Line ID
CL000420
Cell Line Name
SW13
Synonyms
SW-13
SW 13
Scott and White No. 13
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0542
Tissue Information
Adrenal gland
Disease
Adrenal cortex carcinoma (NCIt: C9325)
Adrenocortical carcinoma (ORDO: Orphanet_1501)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01489, 3-oxo-5-alpha-steroid 4-dehydrogenase 2
Compound ID Compound Name Compound Formula
CP0430286
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-phenylbenzamide
   Show/Hide
C32H40N2O2
 1
1
IC50 = 3.75 nM
   TI
   LI
   LO
   TS
CP0043937
(17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one
   Show/Hide
C23H36N2O2
 2
1
IC50 = 4.53 nM
   TI
   LI
   LO
   TS
2
IC50 = 8.47 nM
   TI
   LI
   LO
   TS
CP0150571
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N,N-diethyl-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinoline-1-carboxamide
   Show/Hide
C24H40N2O2
 1
1
IC50 = 7.48 nM
   TI
   LI
   LO
   TS
CP0432509
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-heptylformamide
   Show/Hide
C27H46N2O2
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0462851
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-octylformamide
   Show/Hide
C28H48N2O2
 1
1
IC50 = 18.4 nM
   TI
   LI
   LO
   TS
CP0900049
(10R,13S)-10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione
   Show/Hide
C19H26O2
 1
1
IC50 = 83.9 nM
   TI
   LI
   LO
   TS
CP0907037
(10R,13S,17S)-4-Hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid tert-butylamide
   Show/Hide
C24H37NO3
 1
1
IC50 = 172 nM
   TI
   LI
   LO
   TS
CP0403588
(10R,13S,17S)-4-Chloro-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid tert-butylamide
   Show/Hide
C24H36ClNO2
 1
1
IC50 = 192 nM
   TI
   LI
   LO
   TS
CP0509404
(10R,13S,17S)-4-Bromo-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid tert-butylamide
   Show/Hide
C24H36BrNO2
 1
1
IC50 = 387 nM
   TI
   LI
   LO
   TS
CP0845684
(10R,13S,17S)-4-Mercapto-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid tert-butylamide
   Show/Hide
C24H37NO2S
 1
1
IC50 = 437 nM
   TI
   LI
   LO
   TS
CP0471763
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-2-methyl-N-phenylpropanamide
   Show/Hide
C29H42N2O2
 1
1
IC50 = 582 nM
   TI
   LI
   LO
   TS
CP0381016
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-methylformamide
   Show/Hide
C21H34N2O2
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0399792
5-Bromo-pentanoic acid pentyl-((4aR,6aS,7S,11aR)-1,4a,6a-trimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinolin-7-yl)-amide
   Show/Hide
C29H49BrN2O2
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0399791
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-(3,3-dimethylbutyl)formamide
   Show/Hide
C26H44N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0399860
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-cyclohexylformamide
   Show/Hide
C26H42N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0403856
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-(2-methylpropyl)formamide
   Show/Hide
C24H40N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0440219
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-propan-2-ylformamide
   Show/Hide
C23H38N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0453223
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-pentan-3-ylformamide
   Show/Hide
C25H42N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0453764
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-propylformamide
   Show/Hide
C23H38N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0455135
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-cyclopropylformamide
   Show/Hide
C23H36N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0472249
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-pentylformamide
   Show/Hide
C25H42N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0483644
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-benzylformamide
   Show/Hide
C27H38N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0502400
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-hexylformamide
   Show/Hide
C26H44N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0505951
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-(3-methylbutyl)formamide
   Show/Hide
C25H42N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0514242
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-butylformamide
   Show/Hide
C24H40N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0515956
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-pentylbenzamide
   Show/Hide
C31H46N2O2
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0375240
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-(4-methoxyphenyl)-2-methylpropanamide
   Show/Hide
C30H44N2O3
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0383371
N-[(1S,5aR,9aR,11aS)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,8,9,9b,10,11-tetradecahydroindeno[5,4-f]quinolin-1-yl]-N-methylformamide
   Show/Hide
C20H32N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0440198
N-[(1S,5aR,9aR,11aS)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinolin-1-yl]-N-methylformamide
   Show/Hide
C20H30N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0441797
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-(4-methoxyphenyl)benzamide
   Show/Hide
C33H42N2O3
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0447880
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-2-methyl-N-(4-nitrophenyl)propanamide
   Show/Hide
C29H41N3O4
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0453967
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-pentylpentanamide
   Show/Hide
C29H50N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0462979
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-pentylpropanamide
   Show/Hide
C27H46N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0463729
N-[(1S,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,8,9,9b,10,11-decahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-methylformamide
   Show/Hide
C21H32N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0469224
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
   Show/Hide
C30H40F3N3O4
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0472243
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-butylacetamide
   Show/Hide
C25H42N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0502335
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,9b,10,11-decahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-methylformamide
   Show/Hide
C21H32N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0509782
N-[(1S,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]-N-pentylbutanamide
   Show/Hide
C28H48N2O2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Adrenal gland)
Cell Line Name Organism Disease
NCI-H295R Homo sapiens (Human) Adrenal cortex carcinoma
Y1 Mus musculus (Mouse) Mouse adrenal cortical carcinoma
PC12 Rattus norvegicus (Rat) Rat adrenal gland pheochromocytoma
123.7 Rattus norvegicus (Rat) Rat adrenal gland pheochromocytoma
CAD Mus musculus (Mouse) -